JPRN-UMIN000045820已完成未知
A Database Study to evaluate the Effect of Cancer Cachexia (Weight loss) on Anti-Cancer Drug in Patients with Pancreatic Cancer who receive the first line Chemotherapy - Database Study to evaluate the Effect of Cancer Cachexia (Weight loss) on Anti-Cancer Drug in Patients with Pancreatic Cancer
Ono Pharmaceutical Co., Ltd.0 个研究点目标入组 1,897 人开始时间: 2021年10月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,897
研究概览
简要总结
Cancer cachexia was tended to be associated with shorter TTF and reduced number of doses in patients with pancreatic cancer who received first-line chemotherapy
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pancreatic cancer stage < 3 on the first day of initial chemotherapy Patients who received initial chemotherapy < 60 days followed by surgery Patients who have undergone surgery for pancreatic cancer between the most recent diagnosis of pancreatic cancer and the start of initial chemotherapy. Relapsed patients without initial surgery Relapsed patients without initial information Relapsed patients without initial postoperative chemotherapy Recurrence less than 183 days after completion of initial postoperative chemotherapy Patients with recurrent pancreatic cancer of stage 3 or higher at the initial onset who have received preoperative chemotherapy for at least 60 days
研究者
相似试验
进行中（未招募）
不适用
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary CaregiversAdvanced Malignant Solid NeoplasmCaregiverMetastatic Malignant Solid NeoplasmRecurrent LeukemiaRecurrent LymphomaRecurrent Malignant Solid NeoplasmRecurrent Plasma Cell MyelomaNCT04090619M.D. Anderson Cancer Center192
招募中
Unknown
A study of treatment of cancer cachexia and for reducing side effects of cancer treatment with conditioned mediumCancer cachexia, Side effects of cancer treatmentJPRN-jRCT1051220093Inami Norihito Norihito20
已完成
不适用
Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma RecurrenceCirculating Tumor Cell;Hepatocellular CarcinomaNCT02032368Guangdong Provincial People's Hospital57
已完成
不适用
Football Fitness After Breast CancerBreast Neoplasm FemaleNCT03284567University of Copenhagen69
已完成
2 期
Schedules of Nab-Paclitaxel in Metastatic Breast CancerMetastatic BreastcancerNCT01746225ETOP IBCSG Partners Foundation258